Matthew T. Roe, MD, MHS
Department / Division
Medicine /
Medicine - Cardiology
Address
DUMC 3850
Durham, NC 27710
Appointment Telephone
919-681-5816
Office Telephone
919-668-8959
Fax Telephone
919-668-8665
- MD, Duke University School of Medicine, 1989-1993
- Internal Medicine, Duke University Medical Center, 1993-1996
- Cardiology, Cleveland Clinic Foundation, 1996-1999
- MHS, Duke University School of Medicine, 2001
Clinical Interests
Coronary artery disease, hypertension, hyperlipidemia, peripheral arterial disease
Research Interests
1) Acute Coronary Syndromes
- Risk Stratification in the Emergency Department
- Optimal Use of Anti-Platelet and Anti-Thrombotic Therapies
- Timing of Treatment with Platelet GP IIb/IIIa Inhibitors
- Early Invasive Management Treatment Strategies
2) Reperfusion Strategies for Acute Myocardial Infarction
- Using Biomarker Arrays to Evaluate Therapies in Phase II Trials
- Combination Reperfusion Therapy with Partial-Dose Fibrinolytics and GP IIb/IIIa Inhibitors
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- AstraZeneca
- Bristol-Myers Squibb
- Daiichi Sankyo Co., Ltd
- Eli Lilly & Co.
- Elsevier
- GlaxoSmithKline
- Janssen Pharmaceuticals (Johnson & Johnson)
- Merck
- Regeneron Pharmaceuticals
